Carl H. June, MD, to receive award for translational scientific research
Click Here to Manage Email Alerts
Carl H. June, MD, will receive the inaugural Maria I. New International Prize for Biomedical Research.
The award — presented by Icahn School of Medicine at Mount Sinai and named after Maria I. New, MD, professor of pediatrics, genetics and genomic sciences — recognizes distinguished biomedical researchers whose lifetime scientific achievements led to or may lead to new ways to prevent or treat diseases.
The award includes a $20,000 prize. June also will present an award lecture in November.
June — one of the inventors of chimeric antigen receptor T-cell therapy — is professor in immunotherapy in the department of pathology and laboratory medicine at Perelman School of Medicine at University of Pennsylvania. He also is director of Center for Cellular Immunotherapies and Parker Institute for Cancer Immunotherapy.
“Carl June’s discoveries helped usher a new era in cancer treatment options,” Mone Zaidi, MD, PhD, MACP, director of Mount Sinai's Center for Translational Medicine and Pharmacology, professor of clinical medicine at Icahn School of Medicine at Mount Sinai and chair of the international jury that awarded the prize, said in a press release. “As its inaugural recipient, Carl exemplifies a distinguished scientist whose achievements have led to a transformative treatment paradigm for otherwise debilitating cancers and, by doing so, has upheld the legacy of Dr. Maria New and her lifetime contributions.”
Click Here to Manage Email Alerts